default author photo

Akihiko Sato

Hokkaido University - Division of Molecular Pathobiology

5 Kita 8 Jonishi, Kita Ward

Hokkaido Prefecture

Sapporo, 060-0808

Japan

SCHOLARLY PAPERS

2

DOWNLOADS

69

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Broad Neutralization Activity of SARS-CoV-2 Antibody is Achieved by Coordinated Recognition of Virus Vulnerable Site

Number of pages: 52 Posted: 01 Apr 2021
National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, Hokkaido University - Laboratory of Biomolecular Science, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, Hokkaido University - Division of Molecular Pathobiology, Hokkaido University - Center for Research and Education on Drug Discovery, Osaka University - Laboratory of Lymphocyte Differentiation, Hokkaido University - Laboratory of Biomolecular Science, Hokkaido University - Laboratory of Biomolecular Science, Hokkaido University - Laboratory of Biomolecular Science, Hokkaido University - Laboratory of Biomolecular Science, Hokkaido University - Laboratory of Biomolecular Science, Hokkaido University - Division of Molecular Pathobiology, Hokkaido University - Division of Molecular Pathobiology, National Institute of Infectious Diseases - Department of Pathology, National Institute of Infectious Diseases - Department of Pathology, National Institute of Infectious Diseases - Department of Pathology, Kyushu University - Department of Virology, Kyushu University - Department of Virology, National Institute of Infectious Diseases - Pathogen Genomic Center, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases - Department of Virology I, Tottori University - Chromosome Engineering Research Center, Tottori University - Chromosome Engineering Research Center, National Institute of Infectious Diseases - Department of Immunology, Trans Chromosomics Inc., Osaka University - Laboratory of Lymphocyte Differentiation, National Institute of Infectious Diseases - Pathogen Genomic Center, National Institute of Infectious Diseases - Department of Pathology, Hokkaido University - Division of Molecular Pathobiology, Kyushu University - Department of Virology, Hokkaido University - Laboratory of Biomolecular Science and National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development
Downloads 49 (1,074,648)

Abstract:

Loading...

2.

​In vivo antiviral efficacy and safety of 5-hydroxymethyltubercidin against DENV2 and SARS-CoV-2​

Number of pages: 21 Posted: 25 Apr 2026
Shionogi & Co. Ltd. - Shionogi Pharmaceutical Research Center, Shionogi & Co. Ltd. - Shionogi Pharmaceutical Research Center, affiliation not provided to SSRN, Hokkaido University - Division of Molecular Pathobiology, Hokkaido University - Division of Molecular Pathobiology, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Hokkaido University, Hokkaido University, Hokkaido University - Division of Molecular Pathobiology and Hokkaido University - Laboratory of Biomolecular Science
Downloads 20 (1,448,301)

Abstract:

Loading...

Antivirals, Ribonucleoside analog, Broad-spectrum, Dengue virus, SARS-CoV-2, Mouse model